Hans Truong, MD
Diagnostic Radiology · Spring, TXNPI 1518958271
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 119 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 34 manufacturers reported payments, led by CSL Behring at 24.2% of the total. Reporting peaked in 2019 at $912 and has fallen 98.2% since, to $16 in 2025. Among diagnostic radiology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 119 payments — averaging $18.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Behring$527
- Amgen$234
- Eisai Inc.$156
- Merz North America, Inc.$156
- AstraZeneca$143
- SK Life Science, Inc.$139
- plus $825 from 28 others
What the payments were for
- Speaking & faculty fees$151%
- Food & beverage$2,16599%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Behring | 27 | $527 |
| Amgen | 12 | $234 |
| Eisai Inc. | 9 | $156 |
| Merz North America, Inc. | 8 | $156 |
| AstraZeneca(2 entities) | 8 | $143 |
| SK Life Science, Inc. | 7 | $139 |
| Neurocrine Biosciences, Inc. | 6 | $120 |
| AbbVie(2 entities) | 3 | $60 |
| Arbor Pharmaceuticals, Inc. | 3 | $41 |
| Jazz Pharmaceuticals Inc. | 2 | $41 |
| Biogen | 3 | $40 |
| Scilex Pharmaceuticals Inc. | 2 | $34 |
| Harmony Biosciences LLC | 2 | $33 |
| Upsher-smith Laboratories LLC | 2 | $33 |
| Acorda Therapeutics, Inc | 2 | $32 |
| Merck | 2 | $32 |
| Lilly USA, LLC | 2 | $32 |
| Novo Nordisk | 2 | $31 |
| Medtronic | 1 | $30 |
| Astellas Pharma US Inc | 1 | $26 |
| Akcea Therapeutics, Inc. | 1 | $25 |
| Sanofi Pasteur Inc. | 2 | $23 |
| Morphosys, US Inc. | 1 | $22 |
| Azurity Pharmaceuticals, Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| United Imaging Healthcare North America, Inc. | 1 | $16 |
| Neurelis, Inc. | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Avanir Pharmaceuticals, Inc. | 1 | $16 |
| Boehringer Ingelheim | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Exact Sciences | 1 | $13 |
| Sun Pharmaceutical Industries Inc. | 1 | $12 |
| Collegium Pharmaceutical, Inc. | 1 | $12 |
How this compares
$2,180 in reported general payments places this provider in the 90th percentile of 2,506 diagnostic radiology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other diagnostic radiology in Spring
- Chirag ParghiSpring$49K
- Harlan HarveyHouston$583K
- Anthony StavrosSan Antonio$465K
- Steven RoweDallas$407K
- Alexandru BageacFort Worth$339K
- Sasidhar YallampalliHouston$263K
- Debra ButlerHouston$262K
- Melissa PriceHouston$233K
- Vivek BansalHouston$173K
- Stephen RoseHouston$163K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.